Biosensor capsules and systems

By designing a transparent shell and a capsule biosensor system with multi-wavelength radiation, combined with a signal processing circuit, the problem of distinguishing fresh and old blood and data noise in the prior art is solved, and accurate monitoring and bleeding of blood in the gastrointestinal tract is achieved. Real-time judgment of severity.

CN113710154BActive Publication Date: 2024-11-15ENTERASENSE LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202080029471.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-04-18
Filing Date
2020-04-16
Publication Date
2024-11-15
Estimated Expiration
2040-04-16

AI Technical Summary

Technical Problem

Existing wireless biosensors are difficult to effectively distinguish fresh bleeding from old blood when monitoring the presence of blood or other fluids in the gastrointestinal tract, and there are problems of insufficient data noise and optical performance.

Method used

A capsule biosensor system was designed, using a transparent shell, LED light source and photodetector, and data processing was performed through multi-wavelength radiation emission and time multiplexing schemes, combined with signal processing circuits, and the ratio and angle difference of specific radiation wavelengths were used. The fluid is present and the severity of the bleeding is determined by the severity index (SI).

Benefits of technology

Accurate identification of blood in the gastrointestinal tract, distinguishing fresh and old blood, reducing data noise, improving optical performance, and ensuring real-time monitoring of active bleeding.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113710154B_ABST
    Figure CN113710154B_ABST
Patent Text Reader

Abstract

A biosensor system having a capsule (1) with a housing configured for ingestion in the gastrointestinal tract of a mammal, in the shape of a cylinder with a domed top end. The housing forms an external space similar to a "cutout" shape, wherein two opposing transparent walls (6 and 7) face each other in the longitudinal direction and the base wall (5) faces radially. An LED emitter (21) emits at multiple wavelengths in a temporal sequence and the radiation is detected by a photodetector (22) through a wall (7) forming a concave lens. An antenna (60) is used to wirelessly transmit data to an external device and is in the form of an overall tapered conical spiral, located in the domed top end (8) for optimal space efficiency. A battery compartment is located at the opposite end of the housing, separated from the antenna (60) by the external space (5, 6, 7).
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a wireless biosensor in the form of a capsule for monitoring the presence of blood or other fluids in the gastrointestinal (GI) tract, and to a system incorporating the biosensor. Background Art

[0002] US7828730B2 describes a device for bleeding detection, comprising a fixture that can be mounted inside a hollow organ, and a detection device connected to the fixture for detecting the presence of blood and measuring a specific absorption spectrum of the contents in the hollow organ. This requires that the sensor be fixed inside at least one organ.

[0003] It is known to use fluorescein as a marker for active bleeding detection. WO2011066431 describes a system and method for a wireless biosensor using fluorescein as a marker.

[0004] EP3269298 (Ovesco Endoscopy) describes a capsule having a recess and a shielding plate for preventing emitted light from bypassing the recess.

[0005] WO2018 / 112389 (Progenity) describes an ingestible device having a detection cavity (22) formed by a recess.

[0006] US2014 / 0296666 (Given Imaging) describes an in vivo sensing device having a plurality of illumination sources on a first side of a gap, each illumination source being used to repeatedly illuminate the fluid within the gap with a different narrowband wavelength to determine a series of blood concentration values. A bleeding event is determined based on the series of blood concentration values ​​and a threshold as a function of time.

[0007] US2014 / 275860 (Given Imaging Ltd) describes a device having a housing including a gap, an illumination source for illuminating an in vivo fluid in the gap, a light detector for detecting light passing through the in vivo fluid in the gap, and flexibility on the housing near the opening of the gap for covering the opening when the fins are folded.

[0008] WO2005 / 113374 (Given Imaging Ltd) describes a device, system and method for in vivo sampling having a sampling chamber and a door mechanism, wherein the sampling chamber can store a sample of body cavity material and the door can close and open an opening of the sampling chamber.

[0009] US 2013 / 0053928 (Daniel Gat) describes a capsule having a transparent shell and one or more radiation sources for treating detected pathological lesions in the gastrointestinal (GI) tract with light during passage of the device through the GI tract.

[0010] The present invention aims to provide an improved wireless biosensor monitor. Summary of the invention

[0011] We describe the biosensor system in various embodiments set out in the accompanying claims 1 to 47 .

[0012] We describe a biosensor system comprising:

[0013] A capsule comprising:

[0014] a housing configured for ingestion in a mammalian gastrointestinal tract and having a longitudinal axis, at least some portion of the housing being transparent to radiation at the sensing wavelength, and wherein the housing is configured to form an exterior space that is open to ingress by a fluid,

[0015] a radiation emitter and a radiation detector arranged to emit radiation into said external space and to detect radiation from said external space through said transparent portion of the housing,

[0016] a drive circuit for the radiation emitter and a signal processing circuit coupled to the detector, and

[0017] Interface with antenna for wireless data transmission to external device and / or processor for local processing and storage of detection data.

[0018] Preferably, the external space is formed by a plurality of walls forming an open space within the enclosure of the housing. Preferably, the housing comprises a base wall facing in a direction having a main radial component, and a first wall and a second wall substantially facing each other in a longitudinal direction, said walls forming said external space. Preferably, at least one of said walls is planar, and preferably all of said walls are planar.

[0019] Preferably, the first wall and the second wall are used to pass radiation in a longitudinal direction for absorption detection of materials in the external space. Preferably, the base wall is used to detect fluorescence emitted in a radial direction in the external space. Preferably, the housing forms a convex lens for radiation from the emitter into the external space and a concave lens for radiation into the detector.

[0020] Preferably, the shell forms the external space with a dimension in the longitudinal direction in the range of 2 mm to 7 mm. Preferably, the first wall and the second wall are radially open outward relative to each other. Preferably, the length of the shell in the longitudinal direction is in the range of 15 mm to 30 mm, and its maximum width dimension is in the range of 5 mm to 12 mm.

[0021] Preferably, the housing enclosure shape is generally cylindrical with a domed end portion.Preferably, the housing comprises a plurality of parts bonded together, and the part forming said exterior space is transparent to said radiation.

[0022] Preferably, the housing comprises a fluorescence detector arranged to detect fluorescence through a transparent portion of the housing, and said detection may be simultaneous with or separate from the absorption detection.

[0023] Preferably, the signal processing circuit comprises a processor mounted on a controller circuit board, the controller circuit board extending in the longitudinal direction and overlapping the external space. Preferably, the wireless interface comprises an antenna mounted in the dome end portion of the housing. Preferably, the antenna is in the form of a spiral, the diameter of which decreases in a direction towards the end of the housing.

[0024] Preferably, the antenna has a maximum radial dimension in the range of 7.5 mm to 9 mm and it narrows to form a tip having a radial dimension in the range of 2 mm to 4 mm. Preferably, the number of turns of the antenna is in the range of 7 to 10. Preferably, the outer envelope of the antenna shape substantially forms an angle in the range of 60° to 80° with the longitudinal axis.

[0025] Preferably, the wireless interface comprises RF circuitry located physically adjacent to the antenna, on a longitudinally extending board.

[0026] Preferably, the signal processing circuit comprises a processor mounted on a longitudinally extending circuit board. Preferably, the capsule comprises a power management circuit board mounted transversely across the housing and defining a space for a battery compartment. Preferably, the battery compartment is also defined by a circuit board for a radiation emitter.

[0027] Preferably, the radiation emitter comprises one or more LEDs and the detector comprises one or more photodetectors.Preferably, the signal processing circuit is configured to take multiple readings of a particular wavelength of radiation and to eliminate outliers and average the non-outlier readings.

[0028] Preferably, the transmitter comprises a plurality of transmitter devices, each transmitter device being adapted to transmit at a specific wavelength, and the drive circuit is configured to actuate each transmitter device according to a time multiplex scheme.Preferably, the time interval between actuations is in the range of 2 ms (milliseconds) to 5 ms.

[0029] Preferably, the signal processing circuit is configured to take radiation readings when the transmitter is not actuated and use the readings as a basis or control to eliminate background noise.

[0030] Preferably, the signal processing circuit is configured to determine an indication of the presence of a particular fluid based on a ratio of a detection signal at one emitter wavelength to a detection signal at another emitter wavelength. Preferably, there is a specific ratio threshold for each of the plurality of radiation wavelength combinations.

[0031] Preferably, the combination comprises one or more of: red: green, far red: green, red: blue, far red: blue, far red: red. Preferably, the signal processing circuit is configured to determine the indication of the presence of a particular fluid based on determining an angle as the difference in wavelength divided by the arc tangent of the difference in the detection signal, and comparing the determined angle to a threshold angle.

[0032] Preferably, the signal processing circuit is configured to determine a severity value indicative of the presence of a particular fluid based on the detected signal amplitude of the one or more wavelengths of radiation.Preferably, the severity value is an indicator of the extent of internal bleeding.

[0033] Preferably, the signal processing circuit is configured to determine the proportion of the decrease in detection signal strength for one or more transmitter wavelengths as a parameter for determining the severity value.Preferably, the signal processing circuit (50) is configured to monitor changes in the detection signal value as an indicator of the extent of internal gastrointestinal bleeding.

[0034] Preferably, the signal processing circuit is configured to determine that if the severity index is rising, this indicates the presence of fresh blood rather than historical or previous bleeding.

[0035] Preferably, the biosensor system further comprises a receiver for receiving and processing the radiation signal emitted by the capsule. Preferably, said receiver comprises some of said signal processing circuitry. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] The invention will be more clearly understood from the following description of some embodiments given by way of example only, with reference to the accompanying drawings, in which:

[0037] Figure 1 and 2 is a perspective view of a biosensor capsule of the sensing system, Figure 3 is its side view;

[0038] Figure 4 is a bottom perspective view of the top housing portion;

[0039] Figure 5(a) and 5(b) are side and perspective views of the bottom housing portion;

[0040] Figure 6 is a perspective view of the capsule with the top housing portion removed;

[0041] Figure 7(a) and 7(b) are perspective views of the top and bottom of the internal components of the sensor, respectively;

[0042] Figure 8 is a side view of the capsule’s antenna;

[0043] Fig. 9 is the block diagram of the sensing system;

[0044] Fig.10 is a block diagram of a receiver-side architecture of a system including a sensor;

[0045] Fig.11 is a flow chart showing one example of operating the system;

[0046] FIG12(a) is a schematic diagram of an LED driving scheme with time multiplexing, and FIG12(b) is a graph of a voltage parameter sensed by a capsule versus a severity index (“SI”), FIG12(c) is a graph showing the difference in transfer characteristics between old blood and fresh blood and how it is used for SI calculation, and FIG12(d) is a circuit diagram of a device for sensing emitted light and providing feedback;

[0047] Figure 13(a) and 13(b) is a schematic diagram illustrating alternative light source arrangements, and Figures 14(a) to 14(d) is a schematic diagram showing various detector arrangements;

[0048] Fig.15 is a cross-sectional side view of an alternative sensor, in this case having a fluorescence detector;

[0049] Fig.16 and 17 is a perspective view of the opposite end of the internal components of the alternative sensor;

[0050] Fig.18 It passes through Fig.16 and 17 A schematic cross-sectional view of a sensor; and

[0051] Fig.19 yes Figures 16 to 17 A cutaway perspective view of the sensor. DETAILED DESCRIPTION

[0052] First reference Figure 15, a biosensor capsule 1 of a sensing system is described. The biosensor capsule 1 is configured to be ingested and measure and monitor the presence of blood or other fluids in the gastrointestinal (GI) tract. The capsule 1 is also configured to enable data collection and transmission to a receiver 70 ( Fig.10 ), the receiver 70 also forms part of the sensing system. The data can be viewed in real time and / or stored in an external monitor and / or in a cloud-based system for further viewing and analysis through a user-friendly interface.

[0053] The biosensor capsule 1 is configured to identify blood within the GI tract of a patient. This includes blood that may have accumulated in the patient's stomach for several hours and was not actively bleeding at the time of ingestion ("old blood"). The capsule can also identify the presence of ongoing active bleeding, i.e., blood that has accumulated in the stomach at the time of ingestion. The capsule is configured to distinguish between "old blood" and "active bleeding".

[0054] like Figure 1 As shown in Figures 5 to 5, the capsule 1 includes a shell or housing 2, which includes a top portion 3 and a base portion 4. The shell 2 has a generally cylindrical shape, having first and second domed end portions 8 and 9, and an exterior space "cut-out" volume formed between the domed end portions 8 and 9 by a recess 10 in the shell 2. The cut-out 10 forms a volume within the entire enclosure of the capsule 1 and is formed by three planar walls 5, 6 and 7 of the top portion 3. Wall 6 is transparent to the sensing wavelength of interest and faces the opposite transparent wall 7 in the longitudinal direction, and the base of the cut-out is formed by wall 5. As described in more detail below, the lens walls 6 and 7 are used to pass light in the longitudinal direction for absorption detection of the material within the cut-out volume. As described in more detail below, reference is made to Fig.15 In other embodiments, components of the capsule may be arranged for fluorescein detection in addition to light absorption.

[0055] Although the "cut-out" volume has orthogonal walls 5, 6 and 7 in this example, they can be configured at angles to each other as follows to optimize optical performance.

[0056] The material and geometry of the capsule are chosen to increase the flow of gastric fluid to the notch of the capsule and to reduce the risk of blockage by food and other particles. The way the components are mounted within the housing is very important to minimise volume.

[0057] The base portion 4 and the top portion 3 are releasably attached and the base portion 4 comprises snap fit features 12 and 13. The dimensions of the capsule are:

[0058] Length: 27 mm (mm), preferably in the range of 15 mm to 30 mm.

[0059] Diameter: 11 mm, preferably in the range of 5 mm to 12 mm.

[0060] The lens walls 6 and 7 can be manufactured as one piece and used as the entire top portion 3 of the capsule 1 as in this example. In an alternative arrangement, it can be assembled with the top of the capsule as a cutout component. Or, alternatively, different lenses can be manufactured to provide each wall assembled with the top capsule separately.

[0061] Wall 6 comprises convex lenses to diffuse as much light as possible, while walls 5 and 7 are made of concave lenses to focus as much light as possible. Fig.15 As described, the wall 5 may act as a transparent lens for receiving radiation, for example fluorescent radiation.

[0062] The distance between walls 6 and 7 is 4.5 mm, and more generally, preferably in the range of 2 mm to 7 mm. In various embodiments, the transparent walls facing each other have an angle in the range of 90° to 150° relative to the longitudinal axis, and in the present embodiment, walls 6 and 7 are at a draft angle of 90°+ to facilitate analysis of the contents.

[0063] In various embodiments, the transparent wall is polycarbonate, PMMA, polyethylene terephthalate glycol (PET), amorphous copolyester (PETG), polyvinyl chloride (PVC), liquid silicone rubber (LSR), cyclic olefin copolymer, polyethylene (PE), transparent polypropylene (PP), styrene methyl methacrylate (SMMA), polystyrene, MABS (transparent ABS).

[0064] In this embodiment, there is one "cutout" (a pair of opposing transparent walls). However, in other embodiments, there may be a second cutout portion on the opposite side of the capsule.

[0065] The assembly 20 of the components of the capsule 1 is Figures 6 to 8 . The assembly 20 comprises an LED light source 21 aligned in a longitudinal direction with an absorptive photodetector 22. Several components are mounted on a controller circuit board 30 which extends substantially parallel to the base wall 5 in a longitudinal direction. This is coupled by a flexible cable 31 to an orthogonal transmitter circuit board 32 which supports the light source 21 and associated components. There is also a power supply circuit board 35, whose components include a magnetic switch, a booster and associated components, spaced from the transmitter circuit board 32, defining a space for a battery 45 therebetween. The board 32 is coupled to the board 35 by a semi-flexible PCB 25 held between the fasteners 12 and 13.

[0066] from Figure 6As can be clearly seen in Figures 5 and 7, the arrangement of the longitudinal controller board and the transverse and orthogonal transmitter board and power supply boards 32 and 35 allows for optimal assembly of components, including a relatively large microcontroller 50 in the space below the cutout space base wall 5. The space at the distal end of the cutout 5-7 is optimally utilized to accommodate the battery and associated power supply components. This helps ensure that the capsule is not too large while having sufficient power to support a sensing duration of more than 3 days.

[0067] The microcontroller 50 mounted below the board 30 allows for optimal use of the space between the board and the housing wall. In addition, the board 50 has a recess on one side for a test probe to access the pins of the microcontroller 50 and ensure programming of the microcontroller 50.

[0068] The antenna 60 is in the shape of a spiral with a gradually decreasing diameter to form a conical shape with a top end towards the end 8 of the housing. In the best configuration, the antenna has nine complete circular turns, the largest of which has a diameter of 8.6 mm. The antenna is made of enameled copper with a diameter of 0.35 mm.

[0069] refer to Figure 8 , the antenna has the following parameters.

[0070] Maximum diameter: 7.5 mm to 9 mm

[0071] Tip diameter: 2mm to 4mm

[0072] Number of turns: 7 to 10

[0073] H = 2.5-4 mm (designed to be 2.6, but manufactured to be 3.25)

[0074] Angle: 60° to 80°

[0075] Thread thickness: 0.2mm to 0.5mm

[0076] Material: Enameled copper, but in other embodiments it can be silver, aluminum, stainless steel.

[0077] The antenna may also be encapsulated in a coating. The coating material may be one or more selected from epoxy resin, polyurethane, parylene and benzocyclobutene (BCB), polytetrafluoroethylene (PTFE), perfluoroalkoxyalkane (PFA) and fluorinated ethylene propylene (FEP).

[0078] The antenna is placed at one end of the capsule, at least 5 mm from the battery. Its shape is also designed to maximize the available volume within the capsule.

[0079] Fig. 9The architecture in terms of logic is shown. The microcontroller 50 is physically close to the antenna 60, with RF tuning components on the board 50. The microcontroller 50 also has the following functional blocks in the following order:

[0080] Filter signal conditioning, which is connected to PD 21,

[0081] ADC, in turn connected to storage, encoding functions, and in turn to RF circuits,

[0082] The control block controls the regulation circuit 40 , which is coupled to the power management block on chip 50 .

[0083] Fig.10 A system comprising a capsule 1 is shown, comprising a receiver 70 arranged to receive the radiated signal from the capsule's antenna 60. The receiver side architecture is Fig.10 , and shows a logical layout, where the receiver 70 includes an antenna 71, an evaluation platform receiver 72, and a display 73. There is also a local area network wirelessly coupled to the user device 80.

[0084] Absorption mode uses an optical system to identify blood and takes advantage of the light absorption properties of blood. Each substance has its own light absorption properties, i.e. old blood and active bleeding.

[0085] Also refer to Fig.11 and 12, describe the operation of the capsule and the system. The hardware components of the system are the component 20 within the capsule and the receiver component 70.

[0086] The capsule is ingested and travels along the gastrointestinal tract (GI tract) without any external intervention. The capsule may also contain a position sensor (e.g. based on pH, GPS, etc.) to inform its location along the way. If longer-term monitoring is required, the capsule can be placed in a specific location in the GI tract through minimally invasive surgery. The capsule is configured with a through-hole feature 11 at one end (see Figure 2 ), so that the rope / suture can be fixed to the capsule. The rope / suture can be biodegradable to ensure a dual release mechanism. The suture channel 11 is streamlined, does not affect the overall enclosure of the capsule, and can be selected by the physician for use according to the medical situation if necessary. This allows for excellent versatility.

[0087] The light source 21 emits light of different wavelengths within the visible spectrum, including violet, blue, green, yellow, orange and red. Each substance of the blood has its own light absorption curve, and the wavelength is selected to amplify the irregular characteristics of the blood absorption spectrum. The photodetector 22 covers the entire visible spectrum, detects light and transmits it to the amplifier, which collects the photons and converts them into voltage / current, and then converts them into digital signals.

[0088] The light source may include a single light source or an array of multiple light sources, and similarly the photodetector may be a single photodetector or an array of multiple photodetectors. In one example, the single light source 21 emits light of any one of four wavelengths in the range of 300nm to 900nm, and the photodetector 22 is configured to cover the entire spectrum from 300nm to 900nm.

[0089] Fig.11 An example of a control strategy is shown and FIG12( a) shows an LED light emitter drive pattern. The microcontroller 50 actuates the LEDs to enhance optical performance while limiting power consumption. The evaluation platform 72 is programmed with a decision model and is configured to predict the probability that the medium being analyzed is blood.

[0090] The microcontroller can be configured to pulse the LEDs in sequence for emission at their specific wavelengths, with short pulses being better suited for optimizing the battery. It should be understood that some or all components, such as the photodetector, amplification, microcontroller and RF module, may be integrated.

[0091] As shown in Figure 12(a), the individual wavelengths are actuated with a time delay of 8 ms between them, thus operating a form of time-division multiplexing on the channel between walls 6 and 7. The channel passes through the volume within the cutout defined by walls 5, 6 and 7.

[0092] In one embodiment, the following is the sequence of operation of the capsule.

[0093] The microcontroller enables LED1 (=LED1 is on).

[0094] The microcontroller also enables the photodetector 22 and takes 10-30 measurements from the photodetector 22. The photodetector 22 sends 10 to 30 voltage signals to the microcontroller's ADC. The microcontroller is programmed to eliminate the higher and lower values ​​and average the remaining values. The resulting value, VLED1, is a voltage that is proportional to the absorbed light received by the photodetector when LED1 is on.

[0095] LED1 turns off after about 2ms to 5ms.

[0096] LED2 is now on.

[0097] Photodetector 22 measures VLED2.

[0098] LED2 turns off after 2 to 5ms.

[0099] This sequence is repeated for each LED. When all the LEDs have been pulsed and all the VLEDn (voltage levels for the signals at the relevant emission wavelengths) have been recorded, all the LEDs are switched off and the photodetector makes a new set of measurements with no light source activated. VLED_OFF is a measure of the possible ambient or background light and it is then used to eliminate possible optical background noise.

[0100] At this point, the photodetector is also switched off until a new set of measurements has to be made.

[0101] The frequency of the measurements is programmed according to the clinical situation. When the results show a low risk of bleeding, a slow frequency is implemented (e.g. every 1 - 2 minutes). Once the system detects a possible bleeding, the frequency is automatically updated to ensure better monitoring (e.g. every 2 seconds).

[0102] This data can be used to detect the presence of blood in real - time. For example:

[0103] If LED1 = RED light (620 - 700 nm), LED2 = Far_Red (700 - 750 nm); LED3 = Green light (495 - 570) and LED4 = Blue light (450 - 495), then we have the following conditions to estimate the presence of blood:

[0104] If V RED / V GREEN = R1 > threshold 1 (threshold 1) → blood

[0105] Or, if V FAR_RED / V GREEN = R2 > threshold 2 → blood

[0106] Or, if V RED / V BLUE = R3 > threshold 3 → blood

[0107] Or, if V FAR_RED / V BLUE = R4 > threshold 4 → blood

[0108] Or, if V FAR_RED / V RED = R5 > threshold 5 → blood

[0109] Or, V RED &V GREEN &V BLUE < threshold 6 → blood

[0110] Or, VRED &V FAR_RED &V GREEN &V BLUE <threshold 7 → blood

[0111] Or, arctan(λ GREEN –λ BLUE ) / (V GREEN -V BLUE ) = Θ1 > Θ THRESHOLD 1 → blood

[0112] Or, arctan(λ RED –λ GREEN ) / (V RED –V GREEN ) = Θ2 > Θ THRESHOLD 2 → blood

[0113] Or, arctan(λ FAR_RED –λ RED ) / (V FAR_RED –V RED ) = Θ3 > Θ THRESHOLD 3 → blood

[0114] Wherein, all the thresholds are values within an arbitrary unit range (e.g., 1.8 to 2.2); the threshold is a value within the range of 0 to 300 mV, and Θ THRESHOLD 1 , Θ THRESHOLD 2 , Θ THRESHOLD 3 is an angle within the range of 0° to 70°.

[0115] In the above, λ GREEN , λ BLUE , λ RED , λ FAR_RED are the wavelengths of these colors. For example, for green, it is preferably between 560 - 520 nm.

[0116] If blood is detected using one or more of the above conditions, the severity index (SI) of bleeding can be determined. The severity index (SI) is calculated as the percentage decrease of V RED and / or V GREEN compared to the basic initial value of V RED and / or V GREEN when there is no blood. At higher blood concentrations, the absorption of red and / or green light is higher, and thus the voltage measured by the photodetector 22 decreases, as shown in Fig. 12(b).

[0117] In addition, FIG12(c) shows how the processor distinguishes between fresh blood and old blood. The system can use different lights to detect new blood (bright red blood color) from old blood (which has a brown component due to the oxidation of hemoglobin). For example, the processor can use FR / R for old blood and FR / G for fresh blood. As shown in FIG12(c), there is a significant difference in the values.

[0118] By using at least four wavelengths, more accurate information can be provided, similar to a separated spectrophotometer. High concentrations of blood will also absorb red light, so the presence of blood cannot be determined solely by the ratio, but the absolute value must also be considered. In addition, by considering the absolute value of certain wavelengths (such as green light absorption), the algorithm can be correlated with blood concentration.

[0119] In another embodiment, each light source has a specific wavelength and also has a specific light power that can be adjusted by the microcontroller.The microcontroller can increase or decrease the actuation time of each LED to produce a selected light intensity.

[0120] Alternatively, a resistor may be used to adjust the output light intensity. Referring to Figure 12(d), the circuit may be configured with components such as N-MOSFETs to act as voltage controlled resistors. In this case, an optical sensor photodiode PD2 is provided to feed information back to the microcontroller μC in order to continuously adjust the output. For example, there may be one target for a stationary capsule and a different target for one traveling through the gastrointestinal tract.

[0121] Using any of these mechanisms, a microcontroller can achieve a specific intensity for each LED to control the desired light power output.

[0122] It will be appreciated that the processor provides complete results based on the combination of wavelengths through the instantaneous measurements described above.

[0123] As described above, the severity index (SI) is determined as the percentage decrease of a single wavelength of light from the expected "no blood condition" wavelength of light.

[0124] As mentioned above, it is also advantageous that the capsule can be placed in a single location for a specific period of time.

[0125] Alternative Embodiments

[0126] FIG. 13 shows different arrangements of light sources that can be used in alternative embodiments. One or more separate light emitting diodes (LEDs) provide the desired wavelengths. There may be a light source 200 with a single broadband LED and multiple filter lenses, each providing a relevant wavelength, in this example G, B, R, and Far Red (FIG. 13(a)). As shown in FIG. 13(b), there may be an array 220 of separate LEDs, each providing a specific wavelength.

[0127] Figure 14 shows various options for photodetectors, as follows:

[0128] (a) broadband photodetector 300,

[0129] (b) a plurality of discrete photodetectors 310,

[0130] (c) a component 320 having a plurality of sensitive regions, each sensitive region being sensitive to a particular wavelength,

[0131] (d) Assembly 350 of a broadband PD with a removable cover for selective filtering.

[0132] Light sources, photodetectors and optical components (such as filters, collimators and optical fibers) are assembled to ensure absorbance and fluorescence detection. The distances and angles of the components relative to each other are selected to ensure the performance of the sensor while minimizing the volume and weight of the components.

[0133] refer to Fig.15 , an alternative sensor capsule has some of the same components, indicated by the same reference numerals. In this case, there is a fluorescence detector 560, transparent to light, beneath a filter 570 in contact with the base wall 5. The illumination causing the fluorescence is caused by the operation of the emitter 22, causing fluorescence in the cut-out volume during the time slot for emitting the relevant wavelength.

[0134] Walls 6 and 7 ensure that the light source and detector face each other for absorption-based measurements. Wall 5 is placed at 90° to wall 6 for fluorescence measurements. This will minimize crosstalk between the fluorescence light source and the detector. Together with the optical filter and collimator, this solution ensures good fluorescence measurement performance even in miniaturized environments. The optical filter and collimator can be integrated in lens 3.

[0135] In the case of the intracapsular fluorescein mode, the fluorescein needs to be injected intravenously and pumped throughout the body, and if the patient has active upper gastrointestinal bleeding, some of the fluorescein will leak into the stomach along with the blood.

[0136] In the case of fluorescein, if internal bleeding occurs, the fluorescein reaches the stomach so the system can identify active bleeding.

[0137] refer to Figures 16 to 19 , shows a capsule 500 having a light source 502 and a light detector 503, which have black light absorbing shields (black plastic material) 504 and 505, which respectively surround the path from the light emitter 506 to the shell wall and to the detector 507 on the opposite side of the gap (external space for analysis). Fig.18 and 19 It shows how the light source 502 and the light detector 503 are mounted on the substrate 501 , and the relative positions of these components with respect to the housing 520 .

[0138] Fig.18 and 19 The relationship of the light source and the detector to the housing is shown, showing a housing 520 having a wall 522 near the light source 502 and a wall 523 near the detector 503. In addition, there is a base wall 524 of the outer detection space. Each light absorber 504 and 505 forms a light channel, which is surrounded by a light absorbing material (such as a black plastic material) on four sides, or forms a channel in a fiber optic tube.

[0139] Advantageously, the light absorber absorbs light that is not close to the optical axis between the source and the detector. This helps prevent radiation from being scattered within the capsule and reaching the detector 507 as noise. Noise can also be prevented by light shielding adjacent to the housing wall at the base of the gap.

[0140] This arrangement is very efficient in directing light from the emitter channel into the photodetector for both the absorption and fluorescence modes of operation. For fluorescence, the light from the light source reaches the sample medium to excite the fluorescent material, and only the emitted light reaches the photodetector, the light from the light source being the noise.

[0141] One or both of the light absorbers may be provided by a component attached to the light emitter device, or may be part of the packaging of the light emitter device, or may be part of the housing.

[0142] There may be at least one LED that emits light within the excitation wavelength range of sodium fluorescein, for example, about 490 nm. The photodetector 560 includes a light filter to filter out all unwanted wavelengths except for the light emitted from the excited sodium fluorescein, for example, about 520 nm. The light-to-voltage converter converts the light into voltage in a similar manner as before. The blood that infiltrates the stomach carries the fluorescein with it, and the light produced by the excited fluorescein is proportional to the amount of fluorescein. Thus, the presence and severity of internal bleeding is detected. The fluorescein is rapidly metabolized and becomes ineffective after 20-30 minutes and no longer emits measurable fluorescence. This is a very effective mechanism for detecting active bleeding instantly and in real time. In some uses, this mechanism can be a supplement or alternative to the above-mentioned light detection method. When the capsule is used, it can be configured by the user to use one or both mechanisms.

[0143] The capsule may have one or more sampling regions where blood or other fluids may flow. For example, by having two cutout volumes at the two ends of the capsule on opposite sides relative to the longitudinal axis, the capsule may sample the environment regardless of capsule orientation.

[0144] In other embodiments, the capsule may have a coating of a hydrophilic material, or a pH sensitive coating with a light sensor to assess the state of the coating; this could be used to locate the capsule within the gastrointestinal tract or as a pH monitor.

[0145] The components of the capsule of various embodiments can be combined in different ways to adapt to the environment. For example, different combinations of LED wavelengths can be used. The radiation wavelength can be different from what is described, possibly further outside the visible spectrum. In addition, it is not necessary for the antenna to be all or partly inside the shell. It is envisioned that it can be at least partially mounted on the outside, and some of it can be embedded in the shell material. The radiation emitter drive circuit and the signal processing circuit connected to the detector can have any desired level of data processing capabilities, ranging from basic (processing) for driving the emitter and receiving signals from the detector to more comprehensive processing. In the case of a basic level, more processing will be performed on an external device with which the capsule communicates. On the other hand, the system may include only a capsule in which the signal processing circuit is configured to transmit a fully processed signal for reception by an external computing device.

[0146] The invention is not limited to the described embodiments, but may vary in structure and detail. For example, instead of having the LED and PD on opposite sides of the gap, they may be located on the board, and optical fibers may be arranged to direct light to where the LED is located and receive light from where the PD is located. This would have the benefit of having the active electronic components all mounted on one substrate.

Claims

1. A biosensor system, include: Capsules, including: a housing (2) configured for ingestion into a mammalian gastrointestinal tract and having a longitudinal axis, at least some portions (5, 6, 7) of the housing being transparent to radiation at a sensing wavelength, and wherein the housing is configured to form an exterior space (10) that is open to entry by a fluid, a radiation emitter (21) and a radiation detector (22) configured to emit radiation into the external space and to detect radiation passing through the portion of the housing from the external space, a drive circuit for the radiation emitter and a signal processing circuit (50) coupled to the detector, and an interface having an antenna (60) for wirelessly transmitting data to an external device and / or processor for local processing and storage of the detection data, The signal processing circuit (50) is configured to use different wavelengths of light to distinguish new blood from old blood, and the signal processing circuit (50) is configured to use a ratio of two wavelengths to indicate old blood, and a ratio of a different wavelength to indicate fresh blood.

2. The biosensor system according to claim 1, It is characterized in that The housing forms a convex lens (6) for allowing radiation from the emitter to enter the external space and a concave lens (7) for allowing the radiation to enter the detector.

3. The biosensor system according to claim 1 or 2, It is characterized in that The signal processing circuit (50) includes a processor mounted on a controller circuit board (30) extending in a longitudinal direction and overlapping the external space.

4. The biosensor system according to claim 1 or 2, It is characterized in that The antenna (60) is mounted on the dome-shaped end portion (8) of the housing.

5. The biosensor system according to claim 4, It is characterized in that The antenna (60) is in the form of a spiral, the diameter of which decreases in a direction towards the end of the housing.

6. The biosensor system according to claim 5, It is characterized in that The antenna (60) has a maximum radial dimension in the range of 7.5 mm to 9 mm and it narrows to form a tip having a radial dimension in the range of 2 mm to 4 mm.

7. The biosensor system according to claim 5 or 6, It is characterized in that The number of turns of the antenna is in the range of 7 to 10.

8. The biosensor system according to claim 5 or 6, It is characterized in that The antenna forms a conical shape with an apex at an end facing the housing, and forms an angle with the longitudinal axis in the range of 60° to 80°.

9. The biosensor system according to claim 1 or 2, It is characterized in that The interface includes RF circuitry (61) located physically adjacent to the antenna (60) on a longitudinally extending board (30).

10. The biosensor system according to claim 1 or 2, It is characterized in that The signal processing circuit (50) includes a processor mounted on a longitudinally extending circuit board (30).

11. The biosensor system according to claim 10, It is characterized in that The capsule includes a power management circuit board (35) mounted across the housing and defining a space for a battery compartment.

12. The biosensor system according to claim 11, It is characterized in that The battery compartment is also defined by a circuit board (32) for the radiation emitter.

13. The biosensor system according to claim 1 or 2, It is characterized in that The radiation emitter (21) comprises one or more LEDs, and the detector (22) comprises one or more photodetectors.

14. The biosensor system according to claim 1 or 2, It is characterized in that The signal processing circuit (50) is configured to obtain multiple readings for a particular wavelength of radiation and to eliminate outliers and average the non-outlier readings.

15. The biosensor system according to claim 1 or 2, It is characterized in that The transmitter comprises a plurality of transmitter devices (220), each transmitter device being adapted to transmit at a specific wavelength, and the drive circuit being configured to actuate each transmitter device according to a time multiplexing scheme.

16. The biosensor system according to claim 15, It is characterized in that The time interval between actuations is in the range of 2 to 5 milliseconds.

17. The biosensor system according to claim 1 or 2, It is characterized in that The signal processing circuit (50) is configured to obtain radiation readings when the emitter is not actuated and to use the readings as a basis or control to eliminate background noise.

18. The biosensor system according to claim 1 or 2, It is characterized in that The signal processing circuit (50) is configured to determine an indication of the presence of a particular fluid based on a ratio of the detection signal for one emitter wavelength to the detection signal for another emitter wavelength.

19. The biosensor system according to claim 18, It is characterized in that There is a specific ratio threshold for each of the multiple combinations of radiation wavelengths.

20. The biosensor system according to claim 19, It is characterized in that The combinations include: red:green, far red:green, red:blue, far red:blue or far red:red.

21. The biosensor system according to claim 1 or 2, It is characterized in that The signal processing circuit (50) is configured to determine an indication of the presence of a particular fluid based on determining an angle as the wavelength difference divided by the arc tangent of the detected signal difference and comparing the determined angle to a threshold angle.

22. The biosensor system according to claim 1, It is characterized in that The signal processing circuit (50) is configured to determine a severity value indicative of the presence of a particular fluid based on the detected signal amplitude of one or more radiation wavelengths.

23. The biosensor system according to claim 22, It is characterized in that The severity value is an indicator of the extent of internal bleeding.

24. The biosensor system according to claim 22 or 23, It is characterized in that The signal processing circuit (50) is configured to determine a proportion of a drop in detected signal intensity for one or more emitter wavelengths as a parameter for determining a severity value, and wherein the signal processing circuit (50) is configured to set an intensity for a light source, and wherein the signal processing circuit (50) is configured to set the intensity at a particular time, and wherein the signal processing circuit (50) is configured to control an average luminous intensity over a period of time by controlling the length of an ON duration, and wherein the signal processing circuit (50) includes a light sensor, and the processor is configured to process a feedback signal from the light sensor to adjust a light emitter output.

25. The biosensor system according to claim 24, It is characterized in that The signal processing circuit (50) is configured to set the intensity at a specific time by limiting the light emitter drive current.

26. The biosensor system according to claim 1 or 2, It is characterized in that The signal processing circuit (50) is configured to use the ratio of FR / R to indicate old blood and use the ratio of FR / G to indicate fresh blood.

27. The biosensor system according to claim 1 or 2, It is characterized in that A light absorbing guide (504, 505) is included that surrounds a path between the radiation emitter and / or detector and a wall of the housing.

28. The biosensor system according to claim 27, It is characterized in that The light absorbing guide includes a black material.

29. The biosensor system according to claim 27, It is characterized in that The light absorbing guide includes an optical fiber.